Other
Depreciation
Gilead Sciences Depreciation increased by 3.3% to $93.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.1%, from $97.00M to $93.00M. Over 4 years (FY 2021 to FY 2025), Depreciation shows an upward trend with a 3.0% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026May 7, 2026
How to read this metric
High depreciation relative to revenue may indicate a capital-intensive business model or significant recent investment in infrastructure.
Detailed definition
The systematic allocation of the cost of tangible assets over their useful lives. This non-cash expense reflects the wea...
Peer comparison
Standard accounting metric across all capital-intensive industries.
Metric ID:
other_depreciationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $79.00M | $82.00M | $90.00M | $80.00M | $80.00M | $80.00M | $83.00M | $94.00M | $83.00M | $86.00M | $91.00M | $94.00M | $98.00M | $94.00M | $95.00M | $97.00M | $93.00M | $90.00M | $90.00M | $93.00M |
| QoQ Change | — | +3.8% | +9.8% | -11.1% | +0.0% | +0.0% | +3.8% | +13.3% | -11.7% | +3.6% | +5.8% | +3.3% | +4.3% | -4.1% | +1.1% | +2.1% | -4.1% | -3.2% | +0.0% | +3.3% |
| YoY Change | — | — | — | — | +1.3% | -2.4% | -7.8% | +17.5% | +3.8% | +7.5% | +9.6% | +0.0% | +18.1% | +9.3% | +4.4% | +3.2% | -5.1% | -4.3% | -5.3% | -4.1% |
Range$79.00M – $98.00M
CAGR+3.5%
Avg YoY Growth+2.9%
Median YoY Growth+2.2%
Current Streak2 quarters growth
Depreciation at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's depreciation?
- Gilead Sciences (GILD) reported depreciation of $93.00M in Q1 2026.
- How has Gilead Sciences's depreciation changed year-over-year?
- Gilead Sciences's depreciation decreased by 4.1% year-over-year, from $97.00M to $93.00M.
- What is the long-term trend for Gilead Sciences's depreciation?
- Over 4 years (2021 to 2025), Gilead Sciences's depreciation has grown at a 3.0% compound annual growth rate (CAGR), from $329.00M to $370.00M.
- What does depreciation mean?
- The annual expense representing the aging and usage of physical assets.